Hu antigen specificities of ANNA-I autoantibodies in paraneoplastic neurological disease

Journal of Autoimmunity

Volumn 13, Issue 4, 1999, Pages 435-443

  King, P H ^a,b   Redden, D ^c   Palmgren, J S ^a   Nabors, L B ^a   Lennon, V A ^d  

^a The University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d MAYO CLINIC   (United States)

Author keywords

Hel N1; HuC; HuD; HuR; RNA binding proteins

Indexed keywords

AUTOANTIBODY; RNA BINDING PROTEIN;

ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; ENCEPHALOMYELITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOREACTIVITY; MOLECULAR CLONING; NEUROLOGIC DISEASE; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; PROTEIN FAMILY; SEROLOGY;

EID: 0033371284     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1999.0337     Document Type: Article

References (28)

1. Lucchinetti C.F., Kimmel D.W., Lennon V.A. Paraneoplastic oncologic profiles of patients seropositive for type I anti-neuronal nuclear autoantibodies. Neurology. 50:1998;652-657.
2. Dalmau J., Graus F., Rosenblum M.K., Posner J.B. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine. 71:1992;59-72.
3. Graus F., Elkon K.B., Cordon-Cardo C., Posner J.B. Sensory neuronopathy and small cell cancer: antineuronal antibody that also reacts with the tumor. Am. J. Med. 80:1986;45-52.
4. Graus F., Cordon-Cardo C., Posner J.B. Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. Neurology. 35:1985;538-543.
5. Altermatt H.J., Rodriguez M., Scheithauer B.W., Lennon V.A. Paraneoplastic anti-Purkinje and type I anti-neuronal nuclear autoantibodies bind selectively to central, peripheral, and autonomic nervous system cells. Lab Invest. 65:1991;412-420.
6. Dropcho E.J., King P.H. Autoantibodies against the Hel-N1 RNA-binding protein among patients with lung carcinoma: an association with type I anti-neuronal nuclear antibodies. Ann. Neurol. 36:1994;200-205.
7. King P.H., Levine T.D., Fremeau R.T., Keene J.D. Mammalian homologs of Drosophila ELAV localized to a neuronal subset can bind in vitro to the 3′UTR of mRNA encoding the ld transcriptional repressor. J. Neurosci. 14:1994;1943-1952.
8. Nabors L.N., Furneaux H.M., King P.H. HuR, a novel target of anti-Hu antibodies, is expressed in non-neural tissues. J. Neuroimmunol. 92:1998;152-155.
9. Yao K., Samson M., Reeves R., White K. Gene elav of Drosophila melanogaster: a prototype for neuronal-specific RNA binding protein gene family that is conserved in flies and humans. J. Neurobiol. 24:1993;723-739.
10. Szabo A., Dalmau J., Manley G., Rosenfeld M., Wong E., Henson J., Posner J.B., Furneaux H.M. HuD a paraneoplastic encephalomyelitis antigen contains RNA binding domains and is homologous to elav andsex-lethal. Cell. 67:1991;325-333.
11. Ma W., Cheng S., Campbell C., Wright A., Furneaux H. Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein. J. Biol. Chem. 271:1996;8144-8151.
12. Furneaux H.M. Neuronal nuclear antibodies Type 1 (Hu). Peter J.B., Shoenfeld Y. Autoantibodies. 1996;551-553 Elsevier, Amsterdam.
13. Lennon V.A. Calcium channel and related paraneoplastic disease autoantibodies. Peter J.B., Shoenfeld Y. Autoantibodies. 1996;139-147 Elsevier, Amsterdam.
14. King P.H. Hel-N2: a novel isoform of Hel-N1 which is conserved in rat neural tissue and produced in early embryogenesis. Gene. 151:1994;261-265.
15. Ball N.S., King P.H. Neuron-specific Hel-N 1 and HuD as novel molecular markers of neuroblastoma: a correlation ofHuD messenger RNA levels with favorable prognosis. Clin. Cancer Res. 3:1997;1859-1865.
16. Lennon V.A. The case for a descriptive generic nomenclature: clarification of immunostaining criteria for PCA-1, ANNA-1 and ANNA-2 autoantibodies. Neurology. 44:1994;2412-2415.
17. Sambrook J., Fritsch E.F., Maniatis T. Molecular cloning: a laboratory manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
18. Dalmau J., Furneaux H.M., Cordon-Cardo C., Posner J.B. The expression of the Hu (paraneoplastic encephalomyelitis/sensory neuronopathy) antigen in human normal and tumor tissues. Am. J. Pathol. 141:1992;881-886.
19. Okano H.J., Darnell R.B. A hierarchy of Hu RNA-binding proteins in developing and adult neurons. J. Neurosci. 17:1997;3024-3037.
20. Sakai K., Gofuku M., Kitagawa Y., Ogasawara T., Hirose G., Yamazaki M., Koh C., Yanagisawa N., Steinman L. A hippocampal protein associated with paraneoplastic neurologic syndrome and small cell lung carcinoma. Bioch. Biophys. Res. Comm. 199:1994;1200-1208.
21. Campos A.R., Grossman D., White K. Mutant alleles at the locus elav in Drosophila melanogaster lead to nervous system defects. A developmental-genetic analysis. J. Neurogenet. 2:1985;197-218.
22. Robinow S., Campos A., Yao K., White K. The elav gene product of Drosophila, required in neurons, has three RNP consensus motifs. Science. 242:1988;1570-1572.
23. Kenan D.J., Query C.C., Keene J.D. RNA recognition: towards identifying determinants of specificity. Trends Biochem. Sci. 16:1991;214-220.
24. Manley G.T., Smitt P.S., Dalmau J., Posner J.B. Hu antigens: reactivity with Hu antibodies, tumor expression, and major immunogenic sites. Ann. Neurol. 38:1995;102-110.
25. King P.H. Differential expression of the neuroendocrine genes Hel -N1 and HuD in small-cell lung carcinoma: evidence for down-regulation of HuD in the variant phenotype. Int. J. Cancer. 74:1997;378-382.
26. Posner J.B. Anti-Hu autoantibody associated sensory neuropathy/encephalomyelitis: a model of paraneoplastic syndrome. Perspect. Biol. Med. 38:1995;167-181.
27. Dalmau J., Posner J.B. Neurologic paraneoplastic antibodies (anti-Yo; anti-Hu; anti-Ri): The case for a nomenclature based on antibody and antigen specificity. Neurology. 44:1994;2241-2246.
28. Dropcho E.J. Autoimmune central nervous system paraneoplastic disorders: mechanisms, diagnosis, and therapeutic options. Ann. Neurol. 37:1995;S102-S113.